Perrigo Announces FDA Final Approval for Desloratadine -

Perrigo Company/PRNewswire

Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets (5 mg).

The 4th Latin Consumer Summit arrives in Miami to explore the Hispanic consumer and growth across the region

Read More The 4th Latin Consumer Summit arrives in Miami to explore the Hispanic consumer and growth across the region
Interface Systems Releases 2026 Retail Loss Prevention Benchmark Report

Read More Interface Systems Releases 2026 Retail Loss Prevention Benchmark Report
Prefix Secures $7.5M to Scale its Facility Management Solution Bringing 3x Efficiency Gains to Retail and Restaurant Operators

Read More Prefix Secures $7.5M to Scale its Facility Management Solution Bringing 3x Efficiency Gains to Retail and Restaurant Operators
Fintech Debuts Supply Chain Partner Management Hub to Modernize Traditional Scan-Based Trading

Read More Fintech Debuts Supply Chain Partner Management Hub to Modernize Traditional Scan-Based Trading

Perrigo Announces FDA Final Approval for Desloratadine

The 4th Latin Consumer Summit arrives in Miami to explore the Hispanic consumer and growth across the region

Interface Systems Releases 2026 Retail Loss Prevention Benchmark Report

Prefix Secures $7.5M to Scale its Facility Management Solution Bringing 3x Efficiency Gains to Retail and Restaurant Operators

Fintech Debuts Supply Chain Partner Management Hub to Modernize Traditional Scan-Based Trading

Login · Register

Explore

Sponsors

About